about
HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cellsMorphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral coreHuman immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible?Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex.Identification and characterization of human herpesvirus 8 open reading frame K9 viral interferon regulatory factor by a monoclonal antibody.Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.Effect of splenectomy on T-cell subsets and plasma HIV viral titers in HIV-infected patients.AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.Interactions between human immunodeficiency virus type 1 reverse transcriptase, tRNA primer, and nucleocapsid protein during reverse transcription.1999: a time to re-evaluate AIDS vaccine strategies.Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases.Impact of genotypic resistance testing on physician selection of antiretroviral therapy.Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus.Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India.Public support for medical research in the 21st century.In vitro phenotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo.HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.Role of the CCR5 delta 32 allele in resistance to HIV-1 infection in west Africa.Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection.Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.Human T-lymphotropic virus type I tax polymorphisms in a transmission cohort: no association between sequence variation and disease manifestations.Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors.Diversity of HIV-1 subtype E in semen and cervicovaginal secretion.Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.Neonatal herpes simplex virus infection presenting with fever alone.Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation.Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.Neoplastic AIDS-associated Kaposi's sarcoma cell line KSY-1 cannot transdifferentiate into capillaries.Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
P1433
Q28375966-C5EA56FE-CD53-41AD-AECD-1454FA0338D5Q28646667-8221C9D1-E603-4DD3-B080-BE260D66DC0FQ30233652-997C8952-E733-4476-A535-345A4C81CEFCQ30668836-4F554E12-109F-4AB2-BB75-0365EA26AF08Q30670306-5DD8F288-5C53-4AC4-9BA1-C84231D39763Q30679027-731C35E5-6B92-483E-850C-B450525A5302Q30686007-86B86AB0-08AB-4A95-A7AF-63F83DB91064Q32050235-824E148F-55D8-4B5D-AC04-13FD1D47F7DCQ32050249-131ACC99-1FA4-4A54-87D3-A8CDCF4A975DQ33328466-11D23EBA-40D7-4A86-8D90-77A6237E6484Q33589404-CF70F194-42A1-4AF4-9A40-F58B412D3B47Q33896270-20CA6CEC-4A56-4D27-A993-FAEBF5D7FB4BQ33941297-7B25790D-22E9-46BF-B94E-3A7B78442933Q34082916-34DB2EA3-7ADC-4571-8879-BEC043BB0CACQ34428826-0E11CAD7-F23A-43D0-B076-4D92BC67E8F6Q34916744-EB2C6909-3820-4D91-B5F1-B711EB4C4350Q36667058-66562843-35D2-4454-8B21-0AED4B65D0AFQ38310767-3C121D7E-4280-40E1-8732-580CC8BEFB64Q38313110-FA588420-61B4-4D21-AA81-67DC7288F258Q38473813-6C80951F-09E5-47C0-B6F4-68DAEAD800BDQ38880913-39E28E55-0955-4B65-A49F-D672A5F79C18Q38895186-0EC5B2B8-9E7C-42CC-8222-BA1EE3A31A3FQ39143784-F00BA5E2-2DD5-47E5-9185-62F3FB45192CQ39279556-BA921AE3-1D64-41FC-A27F-4FC26FB58B17Q39331476-94696F75-C30A-42D4-B18F-40D738A35787Q39426667-BA487A27-DFAE-4418-B7E8-5FAD97A430F1Q39449942-B7EF5F79-E92C-4157-9243-9BB24BFEEA10Q39458582-9C973924-789D-48B5-A371-D1D5BFC86817Q39496672-9ECE34B0-4707-445E-9175-9BACFAB8CE87Q39500415-CB5DA819-E6DE-4404-8C9F-C7164DA09EDDQ39623732-CA6222A5-09FD-4D61-B595-0CD86A583D1EQ40593729-D5C77848-B26A-4621-B6C3-7ADA89D861B5Q40684736-7DB98F0D-1243-4639-B0A7-F33A1A91D754Q40722584-AB737A8A-D261-4E89-9001-DB1726F35784Q40743160-BAF2B175-DCEF-44FA-A571-AE1C495C9B97Q40770449-376C00EE-0EF9-4737-A25A-F6889D7980A0Q40794971-73B66B59-B026-4D67-8F9A-605F2D5C37CCQ40885127-94DDF013-3CA6-43E8-B95C-479D0C0507B4Q40919338-B14A299D-D271-4F81-B4A6-62CCE83EFD35Q40940883-267640D6-E83D-407B-A3DA-5C465B63501B
P1433
description
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
scientific journal
@en
wetenschappelijk tijdschrift van Lippincott Williams & Wilkins
@nl
wissenschaftliche Fachzeitschrift
@de
науковий журнал
@uk
مجلة
@ar
name
Journal of Human Virology
@ast
Journal of Human Virology
@de
Journal of Human Virology
@en
Journal of Human Virology
@es
Journal of Human Virology
@fr
Journal of Human Virology
@it
Journal of Human Virology
@nl
type
label
Journal of Human Virology
@ast
Journal of Human Virology
@de
Journal of Human Virology
@en
Journal of Human Virology
@es
Journal of Human Virology
@fr
Journal of Human Virology
@it
Journal of Human Virology
@nl
prefLabel
Journal of Human Virology
@ast
Journal of Human Virology
@de
Journal of Human Virology
@en
Journal of Human Virology
@es
Journal of Human Virology
@fr
Journal of Human Virology
@it
Journal of Human Virology
@nl
P1055
P1058
P1156
P1476
Journal of Human Virology
@en